血小板凝集装置市場：製品、用途、エンドユーザー別-2025～2030年の世界予測

血小板凝集装置市場は、2023年に5億1,726万米ドルと評価され、2024年には6億563万米ドルに達すると予測され、CAGR 17.17%で成長し、2030年には15億6,902万米ドルに達すると予測されています。

血小板凝集装置は、医療診断や研究において極めて重要であり、主に出血性疾患の特定、抗血小板療法のモニタリング、血栓状態の把握に不可欠な血小板機能の評価に使用されます。これらのデバイスの必要性は、心血管疾患や出血性障害の有病率の増加や、リスクを軽減するために正確な血小板機能モニタリングが必要となる外科手術の世界の増加に起因しています。一般的な用途は、病院の検査室、研究機関、血液バンクなどで見られ、臨床診断と研究の両方における重要性が強調されています。最終用途の範囲としては、病院、診断ラボ、学術研究機関が注目すべき消費者であり、医療と科学的探求における重要な関連性を強調しています。

市場成長は、高齢者の増加、医療技術の進歩、個別化医療のための研究投資の増加によって大きく左右されます。もう一つの重要な促進要因は、止血以外の血小板機能に対する理解が広がり、腫瘍学や免疫学などのセグメントにまで踏み込んでいることです。最新の市場開拓の機会は、費用対効果が高く、携帯可能でユーザーフレンドリーなデバイスの開発、遠隔モニタリングのためのデジタル医療プラットフォームの統合、新興国市場での用途の拡大にあります。とはいえ、厳しい規制環境、高額な機器コスト、機器操作のための専門要員の必要性といった課題が、市場拡大を阻害する可能性もあります。また、一部の地域では、これらの機器を必要とする状況についての認識が低いこともハードルとなっています。

事業成長のためには、装置の感度と特異性の向上、自動化による操作の容易化、電子カルテ（EHR）との統合の合理化が有望な技術革新の道筋となります。凝集測定のための新規バイオマーカーの探索や、ニッチな医療セグメントへの機器応用の拡大にも可能性があります。市場競争は緩やかで、革新的なソリューションを持つ新規参入企業や、研究開発や戦略的提携に注力して製品ラインアップを強化する既存企業にも機会があります。技術の進歩を取り入れ、既存の課題に取り組むことで、企業はこの進化する市場環境の中で戦略的なポジションを確立することができます。

市場力学：急速に進化する血小板凝集装置市場の主要市場洞察を公開

血小板凝集装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患の蔓延
  • 血小板凝集装置の入手可能性とアクセシビリティの向上
  • 各国政府による医療支出の増加
• 市場抑制要因
  • 訓練を受けた専門家の不足と機器の高コスト
• 市場機会
  • 遺伝的に獲得された血小板欠損の同定や外科的出血リスクの評価など、新たな応用の可能性
  • 血小板凝集装置における技術の進歩
• 市場課題
  • 厳しい規制ポリシーと医療報酬の制限

ポーターのファイブフォース：血小板凝集装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血小板凝集装置市場における外部からの影響の把握

外部マクロ環境要因は、血小板凝集装置市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：血小板凝集装置市場における競合情勢の把握

血小板凝集装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：血小板凝集装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血小板凝集装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：血小板凝集装置市場における成功への道筋を描く

血小板凝集装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患の蔓延が増加
    • 血小板凝集装置の可用性とアクセシビリティの向上
    • 政府による医療費支出の増加
  • 抑制要因
    • 訓練を受けた専門家の不足と機器の高コスト
  • 機会
    • 遺伝的に獲得した血小板欠陥の特定や手術による出血リスクの評価などの潜在的な新しい用途
    • 血小板凝集装置における技術的進歩
  • 課題
    • 厳格な規制ポリシーと医療費の払い戻し制限
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 血小板凝集装置市場：製品別

• イントロダクション
• 付属品
• 消耗品
• 試薬
• システム

第7章 血小板凝集装置市場：用途別

• イントロダクション
• 臨床
• 研究

第8章 血小板凝集装置市場：エンドユーザー別

• イントロダクション
• 血液バンク
• 診断ラボ
• 病院
• 研究・学術機関

第9章 南北アメリカの血小板凝集装置市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の血小板凝集装置市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血小板凝集装置市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aggredyne, Inc.
• Alpha Laboratories
• Bio/Data Corporation
• Chrono-Log Corporation
• Drucker Diagnostics
• Eurobio Scientific Limited
• F. Hoffmann-La Roche AG
• Haemonetics Corporation
• Matis Medical Inc.
• Sentinel Ch. S.P.A.
• Siemens AG
• Sienco, Inc.
• Sysmex Corporation
• WerfenLife, S.A.

LIST OF FIGURES

• FIGURE 1. PLATELET AGGREGATION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. PLATELET AGGREGATION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PLATELET AGGREGATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PLATELET AGGREGATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PLATELET AGGREGATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PLATELET AGGREGATION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PLATELET AGGREGATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ITALY PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. POLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. QATAR PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM PLATELET AGGREGATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. PLATELET AGGREGATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. PLATELET AGGREGATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Platelet Aggregation Devices Market was valued at USD 517.26 million in 2023, expected to reach USD 605.63 million in 2024, and is projected to grow at a CAGR of 17.17%, to USD 1,569.02 million by 2030.

Platelet aggregation devices are pivotal in medical diagnostics and research, primarily used to assess platelet function-critical in identifying bleeding disorders, monitoring anti-platelet therapies, and understanding thrombotic conditions. The necessity of these devices stems from the growing prevalence of cardiovascular diseases and bleeding disorders, coupled with increasing surgical procedures globally which necessitate precise platelet function monitoring to mitigate risks. Common applications are found in hospital laboratories, research institutions, and blood banks, emphasizing their importance in both clinical diagnostics and research pursuits. As for the end-use scope, hospitals, diagnostic labs, and academic research institutions are notable consumers, underscoring an acute relevance in healthcare and scientific inquiry.

Market growth is significantly influenced by rising geriatric populations, advancing healthcare technologies, and increasing investments in research for personalized medicine. Another crucial growth driver is the expanding understanding of platelet functions beyond hemostasis, delving into areas like oncology and immunology. Latest opportunities lie in developing cost-effective, portable, and user-friendly devices, integrating digital healthcare platforms for remote monitoring, and expanding applications in emerging markets. Nonetheless, challenges such as stringent regulatory environments, high device costs, and the need for specialized personnel to operate these devices could impede market expansion. Limited awareness in some regions about the conditions necessitating these devices also presents a hurdle.

For business growth, enhancing device sensitivity and specificity, facilitating easier operation through automation, and streamlining integration with electronic health records (EHRs) represent promising innovation avenues. There's potential in exploring novel biomarkers for aggregometry and extending device applications into niche medical fields. The market is marked by moderate competition, with opportunities for new entrants possessing innovative solutions and established players focusing on R&D and strategic partnerships to enhance product offerings. By embracing technological advancements and addressing existing challenges, organizations can strategically position themselves in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Platelet Aggregation Devices Market

The Platelet Aggregation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of chronic diseases worldwide
  • Increasing availability and accessibility of platelet aggregation devices
  • Rising healthcare spending by governments
• Market Restraints
  • Lack of trained professionals and high cost of equipment
• Market Opportunities
  • Potential new application such as identification of genetically acquired platelet defects and assessment of surgical bleeding risk
  • Technological advancements in platelet aggregation devices
• Market Challenges
  • Strict regulatory policies and restricted medical reimbursements

Porter's Five Forces: A Strategic Tool for Navigating the Platelet Aggregation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Platelet Aggregation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Platelet Aggregation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Platelet Aggregation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Platelet Aggregation Devices Market

A detailed market share analysis in the Platelet Aggregation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Platelet Aggregation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Platelet Aggregation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Platelet Aggregation Devices Market

A strategic analysis of the Platelet Aggregation Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Platelet Aggregation Devices Market, highlighting leading vendors and their innovative profiles. These include Aggredyne, Inc., Alpha Laboratories, Bio/Data Corporation, Chrono-Log Corporation, Drucker Diagnostics, Eurobio Scientific Limited, F. Hoffmann-La Roche AG, Haemonetics Corporation, Matis Medical Inc., Sentinel Ch. S.P.A., Siemens AG, Sienco, Inc., Sysmex Corporation, and WerfenLife, S.A..

Market Segmentation & Coverage

This research report categorizes the Platelet Aggregation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories, Consumables, Reagents, and Systems.
• Based on Application, market is studied across Clinical and Research.
• Based on End-User, market is studied across Blood Banks, Diagnostic Laboratories, Hospitals, and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases worldwide
    • 5.1.1.2. Increasing availability and accessibility of platelet aggregation devices
    • 5.1.1.3. Rising healthcare spending by governments
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of trained professionals and high cost of equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential new application such as identification of genetically acquired platelet defects and assessment of surgical bleeding risk
    • 5.1.3.2. Technological advancements in platelet aggregation devices
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulatory policies and restricted medical reimbursements
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Platelet Aggregation Devices Market, by Product

• 6.1. Introduction
• 6.2. Accessories
• 6.3. Consumables
• 6.4. Reagents
• 6.5. Systems

7. Platelet Aggregation Devices Market, by Application

• 7.1. Introduction
• 7.2. Clinical
• 7.3. Research

8. Platelet Aggregation Devices Market, by End-User

• 8.1. Introduction
• 8.2. Blood Banks
• 8.3. Diagnostic Laboratories
• 8.4. Hospitals
• 8.5. Research & Academic Institutes

9. Americas Platelet Aggregation Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Platelet Aggregation Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Platelet Aggregation Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aggredyne, Inc.
• 2. Alpha Laboratories
• 3. Bio/Data Corporation
• 4. Chrono-Log Corporation
• 5. Drucker Diagnostics
• 6. Eurobio Scientific Limited
• 7. F. Hoffmann-La Roche AG
• 8. Haemonetics Corporation
• 9. Matis Medical Inc.
• 10. Sentinel Ch. S.P.A.
• 11. Siemens AG
• 12. Sienco, Inc.
• 13. Sysmex Corporation
• 14. WerfenLife, S.A.